FDA Claims 'Manipulated' Data Led to Drug's Approval, Proposes Withdrawal
Summary
Pivotal trial on avacopan was negative before actions of unblinded study personnel, agency says
Description
Pivotal trial on avacopan was negative before actions of unblinded study personnel, agency says
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source